Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 1;28(6):1643-1662.
doi: 10.1212/CON.0000000000001179.

Inflammatory Myopathies

Georgios Manousakis
Review

Inflammatory Myopathies

Georgios Manousakis. Continuum (Minneap Minn). .

Abstract

Purpose of review: This article outlines the salient clinical, serologic, electrophysiologic, imaging, and histopathologic findings and treatment options for the idiopathic inflammatory myopathies, including those related to immune checkpoint inhibitors and SARS-CoV-2.

Recent findings: The classification of idiopathic inflammatory myopathies has improved with the integration of myositis-specific antibodies and histopathologic findings. Characteristic features of immune checkpoint inhibitor-related myositis have been identified, allowing early recognition and treatment of the syndrome. The COVID-19 pandemic has had a profound impact on the care of patients with idiopathic inflammatory myopathies, and several mechanisms of virus-related muscle injury have been proposed.

Summary: A comprehensive evaluation including clinical examination, EMG, imaging, antibody testing, muscle biopsy, and cancer screening, when appropriate, can lead to an earlier accurate diagnosis and an individualized treatment approach for patients with idiopathic inflammatory myopathies.

PubMed Disclaimer

References

    1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts. N Engl J Med 1975;292(7):344–347. doi:10.1056/NEJM197502132920706 - DOI
    1. Allenbach Y, Benveniste O, Goebel HH, Stenzel W. Integrated classification of inflammatory myopathies. Neuropathol Appl Neurobiol 2017;43(1):62–81. doi:10.1111/nan.12380 - DOI
    1. Allenbach Y, Mammen AL, Benveniste O. 224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016. Neuromuscul Disord 2018;28(1):87–99. doi:10.1016/j.nmd.2017.09.016 - DOI
    1. van der Meulen MFG, Bronner IM, Hoogendijk JE, et al. Polymyositis: an overdiagnosed entity. Neurology 2003;61(3):316–321. doi:10.1212/wnl.61.3.316 - DOI
    1. Vilela V, Prieto-González S, Milisenda JC, Selva-o´callaghan A, Grau JM. Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up. Rheumatol Int 2015;35(5):915–920.